From: DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways
Variable | Univariate log rank survival analysis | Multivariate Cox survival analysis | ||||
---|---|---|---|---|---|---|
RR | 95% CI | P value | RR | 95% CI | P value | |
Age (years) | ||||||
< 60 | 1.000 | |||||
≥ 60 | 1.085 | 0.832–1.413 | 0.547 | |||
Gender | ||||||
Male | 1.000 | |||||
Female | 1.091 | 0.797–1.494 | 0.588 | |||
Tumor size (cm) | ||||||
< 5 | 1.000 | |||||
≥ 5 | 1.182 | 1.036–1.349 | 0.013 | 1.387 | 0.827–2.325 | 0.215 |
Invasion depth | ||||||
T1/2 | 1.000 | |||||
T3/4 | 1.610 | 1.098–2.360 | 0.015 | 1.496 | 0.696–3.216 | 0.302 |
Lymphatic metastasis | ||||||
N0 | 1.000 | |||||
N1–3 | 1.369 | 1.056–1.774 | 0.018 | 1.093 | 0.456–2.621 | 0.842 |
Distant metastasis | ||||||
M0 | 1.000 | |||||
M1 | 1.468 | 1.268–1.299 | < 0.001 | 4.364 | 1.830–10.409 | 0.001 |
AJCC stage | ||||||
I/II | 1.000 | |||||
III/IV | 1.500 | 1.214–1.853 | < 0.001 | 1.755 | 0.768–4.011 | 0.183 |
Pathological grade | ||||||
I/II | 1.000 | |||||
III/IV | 1.912 | 1.125–3.250 | 0.017 | 2.077 | 0.863–4.996 | 0.103 |
DDIT4 expression | ||||||
Low | 1.000 | |||||
High | 3.583 | 2.345–4.271 | 0.146 |